PRRT in New Zealand Updates

Latest news
In September 2020, the first patients received PRRT at Auckland DHB. We’re so grateful for the ongoing dedication and commitment by the many government organisations, health professionals and industry partners that enabled this to happen. This is an interim PRRT service, which signals that it is a temporary service that is structured and funded differently to a permanent service. Work is already underway on the transition from an interim to a permanent PRRT service. This transition is expected to be completely seamless for patients. We will keep you posted with news of progress towards the permanent service.

PRRT in New Zealand: a guide for patients

In September 2020 PRRT launched in New Zealand for the first time, thanks to years of Unicorn Foundation NZ advocacy. 

To help patients understand what this treatment involves, Unicorn Foundation NZ has worked with Auckland District Health Board to produce a patient guide.

Screen Shot 2020-11-25 at 10.55.58

Need help with PRRT transport?


Unicorn Foundation NZ can help take the worry out of your treatment journey.

As the national charity helping neuroendocrine cancer patients up and down the country, we understand the uniqueness of these cancers.

With our dedicated Unicorn Foundation NZ car, we’d like to make your PRRT journey easier. We can come and pick you up at the airport and transfer you and your support person safely to your accommodation or appointment. We can also help if you are driving from out of Auckland and feel uncertain on the motorway, or just need a bit of help navigating central Auckland in peak traffic. And of course if you live in Auckland but for any reason need help to get to the hospital in Grafton for your appointments, we’re here for you too.


This service is completely free. Click on the Unicorn car for more information.

IMG_5564 2.jpg

Help us to help others


Neuroendocrine cancer places a big financial burden on patients and their families. Donate now to help us provide free support services.